Cervical cancer: Clinical practice guidelines in oncology

Benjamin E. Greer; Wui Jin Koh; Nadeem R. Abu-Rustum; Sachin M. Apte; Susana M. Campos; John Chan; Kathleen R. Cho; Larry Copeland; Marta Ann Crispens; Nefertiti DuPont; Patricia J. Eifel; David K. Gaffney; Warner K. Huh; Daniel S. Kapp; John R. Lurain; Lainie Martin; Mark A. Morgan; Robert J. Morgan; David Mutch; Steven W. Remmenga; R. Kevin Reynolds; William Small; Nelson Teng; Fidel A. Valea

doi:10.6004/jnccn.2010.0104

Cervical cancer: Clinical practice guidelines in oncology

Benjamin E. Greer, Wui Jin Koh, Nadeem R. Abu-Rustum, Sachin M. Apte, Susana M. Campos, John Chan, Kathleen R. Cho, Larry Copeland, Marta Ann Crispens, Nefertiti DuPont, Patricia J. Eifel, David K. Gaffney, Warner K. Huh, Daniel S. Kapp, John R. Lurain, Lainie Martin, Mark A. Morgan, Robert J. Morgan, David Mutch, Steven W. RemmengaR. Kevin Reynolds, William Small, Nelson Teng, Fidel A. Valea

Obstetrics and Gynecology

Research output: Contribution to journal › Review article › peer-review

65 Scopus citations

Abstract

Cervical cancer is decreasing in the United States because of the wide use of screening; however, it is increasing in developing countries (∼270,000 deaths per year), because screening is not available to many women. Effective treatment for cervical cancer (including surgery and concurrent chemoradiation) can yield cures in 80% of women with early-stage disease (stages I-II) and in 60% of women with stage III disease. The hope is that immunization against HPV (using the new vaccines) will prevent persistent infection with certain types of the virus, and will therefore prevent specific HPV cancer in women.

Original language	English (US)
Pages (from-to)	1388-1416
Number of pages	29
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	8
Issue number	12
DOIs	https://doi.org/10.6004/jnccn.2010.0104
State	Published - Dec 1 2010

Keywords

Cervical cancer
Chemotherapy
Human papillomavirus
Hysterectomy
NCCN clinical practice guidelines
NCCN guidelines
Radiation therapy

ASJC Scopus subject areas

Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.6004/jnccn.2010.0104

Cite this

Greer, B. E., Koh, W. J., Abu-Rustum, N. R., Apte, S. M., Campos, S. M., Chan, J., Cho, K. R., Copeland, L., Crispens, M. A., DuPont, N., Eifel, P. J., Gaffney, D. K., Huh, W. K., Kapp, D. S., Lurain, J. R., Martin, L., Morgan, M. A., Morgan, R. J., Mutch, D., ... Valea, F. A. (2010). Cervical cancer: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 8(12), 1388-1416. https://doi.org/10.6004/jnccn.2010.0104

@article{0ed4bf67931842ffaf7eca4b8f43d545,

title = "Cervical cancer: Clinical practice guidelines in oncology",

abstract = "Cervical cancer is decreasing in the United States because of the wide use of screening; however, it is increasing in developing countries (∼270,000 deaths per year), because screening is not available to many women. Effective treatment for cervical cancer (including surgery and concurrent chemoradiation) can yield cures in 80% of women with early-stage disease (stages I-II) and in 60% of women with stage III disease. The hope is that immunization against HPV (using the new vaccines) will prevent persistent infection with certain types of the virus, and will therefore prevent specific HPV cancer in women.",

keywords = "Cervical cancer, Chemotherapy, Human papillomavirus, Hysterectomy, NCCN clinical practice guidelines, NCCN guidelines, Radiation therapy",

author = "Greer, {Benjamin E.} and Koh, {Wui Jin} and Abu-Rustum, {Nadeem R.} and Apte, {Sachin M.} and Campos, {Susana M.} and John Chan and Cho, {Kathleen R.} and Larry Copeland and Crispens, {Marta Ann} and Nefertiti DuPont and Eifel, {Patricia J.} and Gaffney, {David K.} and Huh, {Warner K.} and Kapp, {Daniel S.} and Lurain, {John R.} and Lainie Martin and Morgan, {Mark A.} and Morgan, {Robert J.} and David Mutch and Remmenga, {Steven W.} and Reynolds, {R. Kevin} and William Small and Nelson Teng and Valea, {Fidel A.}",

year = "2010",

month = dec,

day = "1",

doi = "10.6004/jnccn.2010.0104",

language = "English (US)",

volume = "8",

pages = "1388--1416",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "12",

}

Greer, BE, Koh, WJ, Abu-Rustum, NR, Apte, SM, Campos, SM, Chan, J, Cho, KR, Copeland, L, Crispens, MA, DuPont, N, Eifel, PJ, Gaffney, DK, Huh, WK, Kapp, DS, Lurain, JR, Martin, L, Morgan, MA, Morgan, RJ, Mutch, D, Remmenga, SW, Reynolds, RK, Small, W, Teng, N & Valea, FA 2010, 'Cervical cancer: Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 8, no. 12, pp. 1388-1416. https://doi.org/10.6004/jnccn.2010.0104

TY - JOUR

T1 - Cervical cancer

T2 - Clinical practice guidelines in oncology

AU - Greer, Benjamin E.

AU - Koh, Wui Jin

AU - Abu-Rustum, Nadeem R.

AU - Apte, Sachin M.

AU - Campos, Susana M.

AU - Chan, John

AU - Cho, Kathleen R.

AU - Copeland, Larry

AU - Crispens, Marta Ann

AU - DuPont, Nefertiti

AU - Eifel, Patricia J.

AU - Gaffney, David K.

AU - Huh, Warner K.

AU - Kapp, Daniel S.

AU - Lurain, John R.

AU - Martin, Lainie

AU - Morgan, Mark A.

AU - Morgan, Robert J.

AU - Mutch, David

AU - Remmenga, Steven W.

AU - Reynolds, R. Kevin

AU - Small, William

AU - Teng, Nelson

AU - Valea, Fidel A.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Cervical cancer is decreasing in the United States because of the wide use of screening; however, it is increasing in developing countries (∼270,000 deaths per year), because screening is not available to many women. Effective treatment for cervical cancer (including surgery and concurrent chemoradiation) can yield cures in 80% of women with early-stage disease (stages I-II) and in 60% of women with stage III disease. The hope is that immunization against HPV (using the new vaccines) will prevent persistent infection with certain types of the virus, and will therefore prevent specific HPV cancer in women.

AB - Cervical cancer is decreasing in the United States because of the wide use of screening; however, it is increasing in developing countries (∼270,000 deaths per year), because screening is not available to many women. Effective treatment for cervical cancer (including surgery and concurrent chemoradiation) can yield cures in 80% of women with early-stage disease (stages I-II) and in 60% of women with stage III disease. The hope is that immunization against HPV (using the new vaccines) will prevent persistent infection with certain types of the virus, and will therefore prevent specific HPV cancer in women.

KW - Cervical cancer

KW - Chemotherapy

KW - Human papillomavirus

KW - Hysterectomy

KW - NCCN clinical practice guidelines

KW - NCCN guidelines

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=78951471907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78951471907&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2010.0104

DO - 10.6004/jnccn.2010.0104

M3 - Review article

C2 - 21147903

AN - SCOPUS:78951471907

SN - 1540-1405

VL - 8

SP - 1388

EP - 1416

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 12

ER -

Cervical cancer: Clinical practice guidelines in oncology

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this